Teusch L, Scherbaum N, Böhme H, Bender S, Eschmann-Mehl G, Gastpar M
Department of General Psychiatry, University Hospital, Rhein.Landes- und Hochschulklinik, Essen, Germany.
Pharmacopsychiatry. 1995 May;28(3):84-92. doi: 10.1055/s-2007-979596.
Little is known about sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. In the present study schizophrenic patients (n = 45, mostly under neuroleptic treatment), neurotic patients (n = 50, mostly treated without medication), methadone-substituted opiate addicts (n = 37), and normal controls (n = 41) were included. They were interviewed with the aid of a sex-differentiated semistructured questionnaire on sexual function. All the methadone-substituted opiate addicts and nearly all the schizophrenic patients suffered from dysfunctions in at least one criterion. The three clinical groups differed significantly from the controls in sexual interest, emotional arousal, physiological arousal (erectile function/vaginal lubrication), performance (ejaculatory function/vaginism, dyspareunia), and orgasm satisfaction. Characteristic patterns of dysfunction were found in the male patients. The schizophrenic patients had significantly more dysfunctions of interest, physiological arousal, performance, and orgasm than the controls. Emotional arousal, erectile and ejaculatory functions, and orgasm satisfaction were impaired more frequently in the male schizophrenics than in the neurotic patients. Reduced sexual interest, emotional arousal, and orgasm satisfaction were reported more frequently by the methadone-substituted opiate addicts than by the neurotic men. Emotional arousal was even more frequently reduced than in the schizophrenic men. There was no correlation between sexual dysfunction and particular neuroleptics or neuroleptic or methadone dosage. The results are compared with the literature and suggestions made for further investigations.
关于与精神疾病及精神药物治疗相关的性功能障碍,人们了解甚少。在本研究中,纳入了精神分裂症患者(n = 45,大多接受抗精神病药物治疗)、神经症患者(n = 50,大多未用药治疗)、美沙酮替代的阿片类成瘾者(n = 37)以及正常对照组(n = 41)。借助一份针对性别差异的性功能半结构化问卷对他们进行了访谈。所有美沙酮替代的阿片类成瘾者以及几乎所有精神分裂症患者在至少一项标准上存在功能障碍。这三个临床组在性兴趣、情感唤起、生理唤起(勃起功能/阴道润滑)、性行为表现(射精功能/阴道痉挛、性交困难)以及性高潮满意度方面与对照组有显著差异。在男性患者中发现了功能障碍的特征模式。精神分裂症患者在性兴趣、生理唤起、性行为表现和性高潮方面的功能障碍显著多于对照组。男性精神分裂症患者的情感唤起、勃起和射精功能以及性高潮满意度受损的频率高于神经症患者。美沙酮替代的阿片类成瘾者报告的性兴趣、情感唤起和性高潮满意度降低的频率高于神经症男性。情感唤起降低的频率甚至高于男性精神分裂症患者。性功能障碍与特定的抗精神病药物或抗精神病药物或美沙酮剂量之间没有相关性。将结果与文献进行了比较,并提出了进一步研究的建议。